Medivir

Russia
Artëm, Primorye, Russia, 111 48

Company profile

Medivir company profile

Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. Medivir is a protease inhibitor design and the nucleotide/nucleoside science and we are dedicated to developing innovative pharmaceuticals that meet a great unmet medical need. Our commercial organization provides a portfolio of specialty care, pharmaceuticals on the Nordic market.

Business identity

Contact email
[email protected]
Phone number
+46 (0)85-468-3100
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
1988-01-01, Year

Headquarters

Postal code
111 48
Country code
RU
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$42.6M
Last funding
Post IPO Debt / $2.8M / 2024-10-24
Last equity funding
Post IPO Equity / $1.9M
Investors
1
Lead investors
1
Articles
136
Exited on
2004-10-08

Founders and investors

Lead investors

Linc

Investors

Linc